Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 33B is a member of the C2H2-type zinc finger protein family, potentially involved in transcriptional regulation through DNA binding and nucleic acid binding. The ZNF33B gene is found in a gene cluster in the pericentromeric region of human chromosome 10 and is broadly expressed, though its precise physiological roles remain poorly characterized. Decreased expression has been observed in cumulus cells derived from patients undergoing controlled ovarian stimulation. There are no well-established associations with disease, drug interactions, or biomarker uses, nor is it considered a canonical therapeutic target[1][2][3][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 33B (ZNF33B).